XtalPi
Branden Lee is a seasoned professional in business development and medicinal chemistry, currently serving as Senior Director of Business Development at XtalPi Inc. since March 2024. At XtalPi, a pioneer in AI technology for biopharmaceutical research, Branden focuses on global collaborations in drug discovery and the integration of AI with automated wet lab capabilities. Prior to this role, Branden directed business development at BirdoTech from July 2016 to March 2024. Earlier career experiences include serving as Senior Research Associate at Celgene, specializing in medicinal chemistry and kinase small molecule synthesis, and as a Research Associate at Pfizer, contributing to medicinal chemistry projects. Branden holds an MBA in Marketing and Entrepreneurship from the University of California, San Diego - Rady School of Management, as well as a BS and MS in Chemistry from California State University, Los Angeles.
This person is not in any offices
XtalPi
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.